CASI Pharmaceuticals, Inc. 4
4 · CASI Pharmaceuticals, Inc. · Filed Oct 5, 2016
Insider Transaction Report
Form 4
Ren Ken Keyong
Chief Executive Officer
Transactions
- Award
Stock Options (Right to Buy)
2016-10-03+308,571→ 308,571 totalExercise: $1.11From: 2016-10-03Exp: 2026-10-03→ Common Stock (308,571 underlying)